Hpv-positive Oropharyngeal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-09-19
Clinical Trial Update: Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac [NA]
A clinical trial evaluating adaptive radiation therapy for HPV-positive oropharyngeal cancer patients using MRIdian Linac has been withdrawn…